bpc 157 tga approval bpc-157 BPC-157 10mg – Lyophilised Research Peptide bpc-157 tga approval status BPC-157

Composition BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of two co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Unlike suppliers who conduct in-house testing, every Peptide Warehouse Australia batch is independently tested by Janoshik Analytical, an internationally recognised accredited third-party laboratory

Medical Disclaimer: BPC-157 is a research peptide not approved by the FDA for human therapeutic use

Rats in both experiments were euthanized in a CO 2 chamber at the end of the experiment

Powerlifters operate at the edge of what human tissue can tolerate

At Noor Medical Spa, we believe in the importance of regular monitoring